Hematology NewsFDA grants regular approval to venetoclax for CLL/SLLJune 8, 2018CLLIndolent LymphomaLeukemia, Myelodysplasia, TransplantationLymphoma & Plasma Cell Disorders
Hematology NewsVenetoclax plus ibrutinib yields encouraging MRD results in first-line CLLJune 8, 2018CLLIndolent LymphomaLeukemia, Myelodysplasia, TransplantationLymphoma & Plasma Cell Disorders
Hematology NewsOlder CLL and NHL patients are more vulnerable to toxicitiesMay 23, 2018CLLIndolent LymphomaLymphoma & Plasma Cell Disorders
Hematology News5-year data show deepening response with ibrutinib in CLLMay 11, 2018CLLIndolent LymphomaLeukemia, Myelodysplasia, TransplantationLymphoma & Plasma Cell Disorders
Hematology NewsVenetoclax shows muscle against CLL relapsed after idelalisibApril 18, 2018CLLIndolent LymphomaLeukemia, Myelodysplasia, Transplantation
Hematology NewsUpdated CLL guidelines incorporate a decade of advancesApril 6, 2018CLLIndolent LymphomaLeukemia, Myelodysplasia, TransplantationLymphoma & Plasma Cell Disorders
Hematology NewsExperimental voxtalisib shows mixed results in phase 2 studyMarch 22, 2018CLLAggressive LymphomasLymphoma & Plasma Cell DisordersFollicular Lymphoma
Hematology NewsA global snapshot of leukemia incidenceMarch 13, 2018ALLAMLCLLCMLLeukemia, Myelodysplasia, TransplantationLymphoma & Plasma Cell Disorders
Hematology NewsIbrutinib linked to invasive fungal infectionsMarch 7, 2018CLLPatient & Survivor CareLeukemia, Myelodysplasia, TransplantationIndolent LymphomaMantle Cell Lymphoma
Hematology NewsBaseline stress signals need for psychological help in CLLFebruary 23, 2018CLLLeukemia, Myelodysplasia, TransplantationLymphoma & Plasma Cell Disorders
Hematology NewsCLL Index proves accurate in predicting survival, time to treatFebruary 5, 2018CLLLeukemia, Myelodysplasia, TransplantationLymphoma & Plasma Cell Disorders
Hematology NewsVenetoclax/rituximab boosts PFS in relapsed/refractory CLLDecember 27, 2017CLLLeukemia, Myelodysplasia, Transplantation
Hematology NewsVIDEO: Venetoclax/rituximab prolongs PFS in relapsed/refractory CLLDecember 12, 2017CLLLeukemia, Myelodysplasia, TransplantationAggressive Lymphomas
